What we're reading, November 3, 2016: gubernatorial races could expand Medicaid in 3 more states; genetic testing wastes billions of dollars; most popular Facebook posts on the Zika virus contained inaccurate information or conspiracy theories.
There are still 19 states that have not expanded Medicaid, but 3 more could switch sides after this election. According to The Hill, gubernatorial races in Missouri, North Carolina, and Utah are all leaning toward candidates that support expanding the program. Missouri and North Carolina have Democratic candidates challenging the sitting Republican governors, but in Utah, the incumbent governor is a Republican who supports a small-scale plan to expand Medicaid.
Genetic testing is often touted as a way to revolutionize medicine, but it can waste a lot of money. A study found that a test for inherited thrombophilia cost taxpayers half a billion dollars without providing any medical benefit to patients, reported STAT. Many patients want to get tests even if they don’t offer a clinical benefit that will result in a chance in treatment. One motivating factor for doctors offering these tests is the fear of litigation.
Research has found that while most posts on Facebook about the Zika virus contained accurate information, they were not very popular. Instead, the more popular posts about the virus either had inaccurate information or conspiracy theories, according to Reuters. The research was conducted May and June 2016, when there was a lot of media coverage of Zika.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More